Publications

Theses

  1. Doctor of Philosophy (2006) : The role of Gene Promoter Methylation in Multiple Myeloma
  2. Doctor of Medicine (2002) : Aberrant Gene Promoter Methylation in Acute Promyelocytic Leukemia

Book Chapter

  1. The detection of minimal residual disease in acute leukemia. L Foroni, L Coyle, MF Cole-Sinclair, JC Yaxley, Chim CS, AV Hoffbrand. In : Autologous Stem cell Transplantation: Biological and clinical results in malignancies. Harwood Academic Publisher. Ed. Carella. 1996, p. 89-101.
  2. Optimal Therapy for Multiple Myeloma. JCS Chim, R Liang. In: ASIA PACIFIC ONCOLOGY & HAEMATOLOGY - VOLUME 1, Haematological Cancer

Invited Reviews

  1. Chim CS, et al. Gene Hypermethylation in Multiple Myeloma : Lessons from a Cancer Pathway Approach. Clin Lymphoma Myeloma, 2008 (IF: 1.929)
  2. Chim CS, et al. Adverse Prognostic Impact of CDKN2B Hypermethylation in Acute Promyelocytic Leukemia. Leukemia & Lymphoma; 47(5): 815-825, 2006. (IF: 2.605)
  3. Chim CS, et al. Gene promoter hypermethylation in hematologic malignancies. Hematol Oncol; 20(4):167-76, 2002. (IF: 2.355)
  4. Wong KY, Yu L, Chim CS. DNA methylation of tumor suppressor microRNA genes: a lesson from miR-34 family. Epigenomics, 2011 (IF: 5.215)
  5. Wang LQ, Liang R, Chim CS. Methylation of tumor suppressor microRNAs: Lessons from lymphoid malignancies. Expert Review of Molecular Diagnostics. 2012 Sep;12(7):755-65. (IF: 4.27)
  6. Wong KY, Huang X, Chim CS. DNA methylation of microRNA genes in multiple myeloma. Carcinogenesis. 2012 Sep;33(9):1629-38. (IF: 5.266)
  7. Yim RLH, Kwong YL, Wong KY, Chim CS. DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas. Frontiers in non-coding RNA, Front Genet. 2012;3:233. doi: 10.3389/fgene.2012.00233. (Review)

Best 10 Publications:

  1. YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim. SMILE for natural killer (NK)/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 2012 Oct 11;120(15):2973-80. (IF: 9.775)
  2. KY Wong, Rita LH Yim, CC So, DY Jin, Raymond Liang, CS Chim. Epigenetic inactivation of the MIR34B/C in multiple myeloma. Blood 2011; 118: 5901-5904. (IF: 9.775)
  3. Kwan-Yeung Wong, Raymond Liang, Chi-Chiu So, Yanting Qi, Dong-Yan Jin, Joseph F. Costello, Chor-Sang Chim. Epigenetic silencing of miR-203 in multiple myeloma. Br J Haematol, Sep; 154(5): 569-78. (IF: 4.959)
  4. CS Chim, KY Wong, Y Qi, Loong F, WL Lam, LG Wong, Jin DY, Costello JF, Liang R. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis, 2010, 31(4):745-50. (IF: 5.266)
  5. Chim CS, et al. Epigenetic Dysregulation of Wnt Signaling Pathway in Multiple Myeloma. Leukemia; 21(12): 2527-36, 2007. (IF: 9.379)
  6. Chim CS, Wong SY, Pang A, Chu P, Lau JS, Wong KF, Kwong YL. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia. 2005 Dec;19(12):2241-6. (IF: 9.379)
  7. Chim CS, et al. Nasal NK-cell lymphoma: Long-term treatment outcome and validity of the IPI Index. Blood 2004, 103: 216-221. (IF: 9.775)
  8. Chim CS, et al.SOCS1 and SHP1 Hypermethylation in Multiple Myeloma: Implications for Epigenetic Activation of the Jak/STAT pathway. Blood 2004; 103: 4630-4635. (IF: 9.775)
  9. Chim CS, et al. Long-term outcome of 231 patients with Essential Thrombocythemia: Prognostic factors for bleeding, thrombosis, myelofibrosis and leukaemia. Archives Internal Medicine, 2005, 165: 2651-2658. (IF: 13.246)
  10. Chim CS, et al. p15 and p16 promotor methylation in acute promyelocytic leukaemia. J Clin Oncol, 19: 2033-2040, 2001. (IF: 17.979)

Peer-Reviewed Articles

- N=225 as of Feb, 2015; Authorship: 1st author in 139 (62.3.0%), 2nd author in 17 (7.6%), 3rd author in 9 (4.04%), last in 22 (10%) and corresponding author in >100
- H Factor (using Chim CS, Chim JCS, Chim JC or Chim JS): 31 as of Oct, 2014
- Highest Citation: 200

  1. DNA methylation of tumor suppressor miRNAs in chronic lymphocytic leukemia Lu Qian Wang, Chor Sang Chim Epigenomics. 2015 Feb 4:1-13. (Review)
  2. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma. Qi Zhang, Lu Qian Wang, Kwan Yeung Wong, Zhen Yu Li, Chor Sang Chim. J Clin Pathol, 2015 (in press)
  3. The Role of Magnetic Resonance Imaging in the Management of Patients with Multiple Myeloma: a Consensus Statement on behalf of the International Myeloma Working Group Meletios Athanasios Dimopoulos, Jens Hillengass, Saad Usmani, Elena Zamagni, Suzanne Lentzsch, Faith Davies, Noopur Raje, Orhan Sezer, Sonja Zweegman, Jatin Shah, Ashraf Badros, Kazuyuki Shimizu, Philippe Moreau, Chor-Sang Chim, Juan Jose Lahuerta, Jian Hou, Artur Jurczyszyn, Hartmut Goldschmidt, Pieter Sonneveld, Antonio Palumbo, Heinz Ludwig, Michele Cavo, Bart Barlogie, Kenneth C Anderson, G David Roodman, S. Vincent Rajkumar, Brian Durie, and Evangelos Terpos J Clin Oncol, 2010 Nov 20;28(33):4976-84. (IF: 17.879)
  4. Methylation of miR-155-3p in mantle cell and other non-Hodgkin's lymphoma Rita LH YIM, Kwan Yeung WONG, Yok Lam KWONG, Florence LOONG, Chung Ying LEUNG, Raymond CHU, William W LAM, Pak Kwan HUI, Raymond LAI, Chor Sang CHIM Oncotarget, 2014 Oct 30;5(20):9770-82 (IF: 6.627)
  5. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens. CS Chim, Joycelyn Sim, Sidney Tam, Eric Tse, AKW Lie, YL Kwong. European Journal Hematology, 2014, in press (IF: 2.414)
  6. Bortezomib/bendamustine/dexamethasone induced good partial response in refractory relapse post-ASCT with constitutive RAS activation due to V600E BRAF mutation Chor Sang CHIM, Kwan Yeung WONG Bone Marrow Transplantation, in press, 2014 (IF: 3.466)
  7. RANKL Expression in Myeloma Cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNF in the Microenvironment. Lingqing Yuan, Godfrey Chi Fung Chan, Kwong Lam Fung, CS Chim. BBA - Molecular Cell Research, 2014 Sep;1843(9):1834-8. (IF: 5.297)
  8. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative and beyond Hwang YY, Mohty M, Chim CS Hematology, 2014 Jul 3. [Epub ahead of print] (IF: 1.189)
  9. Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study. Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K, Chou T, Kosugi H, Suzuki K, Chen W, Hou J, Lu J, Huang XJ, Huang SY, Chng WJ, Tan D, Teoh G, Chim CS, Nawarawong W, Siritanaratkul N, Durie BG. Am J Hematol. 2014 Jul;89(7):751-6. (IF: 3.477)
  10. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukemia. Ho Yin Ng, Thomas S Wan, Chi Chiu So, Chor Sang Chim Journal of Clinical Pathology. 2014 Jul;67(7):626-31. (IF: 2.551)
  11. Epigenetic inactivation of miR-34b/c in addition to miR-34a and DAPK1 in chronic lymphocytic leukemia. Lu Qian Wang, Yok Lam Kwong, Kit Fai Wong, Chi Shan Bonnie Kho, Dong Yan Jin, Eric Tse, Anders Rosèn and Chor Sang Chim J Transl Med. 2014 Feb 22;12(1):52.
  12. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFkappaB pathway. Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Mol Cancer. 2013 Dec 27;12:173. (IF: 5.397)
  13. Establishment of a Chinese human multiple myeloma cell line: MMLAL. Kwan Yeung WONG, Thomas SK Wan, Chi Chiu So, Chor Sang Chim. Cancer Cell Int. 2013 Dec 12;13(1):122. (IF: 1.989)
  14. Unsustained CR of less than 24 months after autologous stem cell transplantation predicts aggressive myeloma with short survival. CS Chim, Herman Liu, AKW Lie, EYT Chan, Sandy Ho, Michael Wong and YL Kwong for the Hong Kong Society of Myeloma Hematol Oncol, 2014 Jan 29. (IF: 2.355)
  15. 11C-Acetate for Metabolic Characterization of Multiple Myeloma – A Comparative PET/CT Study with 18F-Fluorodeoxyglucose PET/CT Chi-lai Ho, S Chen, YL Leung, T Cheng, Ka-nin Wong, SK Cheung, R Liang, C S Chim Journal of Nuclear Medicine, 2014 May;55(5):749-52 (IF: 5.563)
  16. New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the international myeloma working group (IMWG). Ocio EM, Richardson PG, Rajkumar SV, Palumbo A, Mateos MV, Orlowski R, Kumar S, Usmani S, Roodman D, Niesvizky R, Einsele H, Anderson KC, Dimopoulos MA, Avet-Loiseau H, Mellqvist UH, Turesson I, Merlini G, Schots R, McCarthy P, Bergsagel L, Chim CS, Lahuerta JJ, Shah J, Reiman A, Mikhael J, Zweegman S, Lonial S, Comenzo R, Chng WJ, Moreau P, Sonneveld P, Ludwig H, Durie BG, San Miguel JF Leukemia. 2013 Nov 20. doi: 10.1038/leu.2013.350. [Epub ahead of print] (IF: 9.379)
  17. Management of multiple myeloma in Asia: resource-stratified guidelines. Tan D, Chng WJ, Chou T, Nawarawong W, Hwang SY, Chim CS, Chen W, Durie BG, Lee JH Lancet Oncol. 2013 Nov;14(12):e571-81. (IF: 24.725)
  18. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm. Zhang MY, Fung TK, Chen FY, Chim CS J Cell Mol Med. 2013 Oct 16. doi: 10.1111/jcmm.12103. [Epub ahead of print] (IF: 3.698)
  19. IMWG consensus on risk stratification in multiple myeloma. Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, San Miguel J, Sonneveld P, Usmani S, Durie BG, Avet-Loiseau H. Leukemia. 2014 Mar;28(3):525-42. (IF: 9.379)
  20. Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Kwong YL, Pang AW, Leung AY, Chim CS, Tse E. Leukemia. 2013 Jul 11. (IF: 9.379)
  21. Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Chan TS, Gill H, Hwang YY, Sim J, Tse AC, Loong F, Khong PL, Tse E, Leung AY, Chim CS, Lie AK, Kwong YL. Ann Hematol. 2014 Mar;93(3):493-8. (IF: 2.396)
  22. An extraordinary survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy. Chim CS, ESK Ma Oncology letter, 2013 Dec;6(6):1663-1664. (IF: 0.987)
  23. Relapses of acute leukemia after allogeneic hematopoietic stem cell transplantation: second transplantation with reduced intensity conditioning from the original donor Leung AYH, Tse E, Hwang YY, Chan TSC, Gill H, Chim CS, Lie AKW, Kwong YL. Am J Hematol, 2013 Jun;88(6):485-91. (IF: 3.477)
  24. Epigenetic inactivation of the MIR129-2 in hematological malignancies. Wong KY, Yim RLH, Kwong YL, Leung CY, Hui PK, Cheung F, Liang R, Jin DY, Chim CS. J Hematol Oncol, 2013: 6, 16. (IF: 4.933)
  25. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, Hajek R, San Miguel JF, Sezer O, Sonneveld P, Kumar SK, Mahindra A, Comenzo R, Palumbo A, Mazumber A, Anderson KC, Richardson PG, Badros AZ, Caers J, Cavo M, Leleu X, Dimopoulos MA, Chim CS, Schots R, Noeul A, Fantl D, Mellqvist UH, Landgren O, Chanan-Khan A, Moreau P, Fonseca R, Merlini G, Lahuerta JJ, Bladé J, Orlowski RZ, Shah JJ. Leukemia. 2012 Nov 21. doi: 10.1038/leu.2012.336. [Epub ahead of print] (IF: 9.379)
  26. Anti-fungal drug usage in hematologic patients during a 4-year period in an Asian university teaching hospital. Chan TS, Hwang YY, Gill H, Cheung WW, Tse E, Leung AY, Chim CS, Lie AK, Kwong YL. Intern Med J. 2013 May;43(5):541-6 (IF: 5.785)
  27. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. Xu C, Fu H, Gao L, Wang L, Wang W, Li J, Li Y, Dou L, Gao X, Luo X, Jing Y, Chim CS, Zheng X, Yu L. Oncogene. 2014 Jan 2;33(1):44-54. (IF: 8.559)
  28. Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide. Chim CS, Choi PT, Lee WK. Annals Hematol. 2013 Jun;92(6):855-7. (IF: 2.396)
  29. Oligoclonal reconstitution masquerading as myeloma relapse. Chim CS, Chan YET. Ann Hematol. 2013 Jun;92(6):847-8. (IF: 2.396)
  30. DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas. Yim RLH, Kwong YL, Wong KY, Chim CS. (Invited review) Frontiers Genet. 2012 Nov 8;3:233.
  31. SMILE for natural killer (NK)/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim. Blood. 2012 Oct 11;120(15):2973-80. (IF: 9.775)
  32. Positron emission tomography in the diagnosis of disseminated pyomyositis due to PVL-negative methicillin-resistant Staphylococcus aureus. Gill H, Kwok H, Mak HK, Chim CS, Kwong YL. QJM. 2013 May;106(5):485-6. (IF: 2.461)
  33. DNA methylation of microRNA genes in multiple myeloma. Wong KY, Huang X, Chim CS. (Invited review) Carcinogenesis. 2012 Sep;33(9):1629-38. (IF: 5.266)
  34. Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD. Chim CS, Lie AKW, Chan YET, et al. for the Hong Kong Society of Myeloma. Journal of Hematology and Oncology. 2012 Jun 8;5(1):28. (IF: 4.933)
  35. Methylation of tumor suppressor microRNAs: Lessons from lymphoid malignancies. Wang LQ, Liang R, Chim CS. (Invited review) Expert Review of Molecular Diagnostics. 2012 Sep;12(7):755-65. (IF: 4.27)
  36. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment. Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL. Clin Transplant. 2012 Sep-Oct;26(5):679-83. (IF: 1.486)
  37. Role of PCDH10 and its hypermethylation in human gastric cancer. Li Z, Chim JC, Yang M, Ye J, Wong BC, Qiao L. Biochim Biophys Acta. 2011 Dec 20. (IF: 5.297)
  38. Methylation of miR-34a, miR-34b/c, miR-124a and miR-203 in Ph-negative myeloproliferative neoplasms. Chim CS, Wan TS, Wong KY, Fung TK, Drexter HG, Wong KF. J Transl Med, 2011 Nov 14;9(1):197. (IF: 3.991)
  39. Epigenetic inactivation of the MIR34B/C in multiple myeloma. KY Wong, Rita LH Yim, CC So, DY Jin, Raymond Liang, CS Chim Blood. 2011; 118: 5901-5904. (IF: 9.775)
  40. MAGIC (MyelomA Genetics International Consortium). Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; San Miguel JF; Chim CS; Browne PV; Einsele H; Waage A; Hajek R; Ludwig H; Turesson I; Spencer A; Hemminki K. Leuk Lymphoma. 2012 May;53(5):796-800. (IF: 2.605)
  41. Atypical Burkitt’s lymphoma transforming from follicular lymphoma. Hwang YY, Loong F, Chung LP, Chim CS Diagnostic Pathol. 2011 Jul 8;6:63. (IF: 2.411)
  42. Epigenetic silencing of miR-203 in multiple myeloma. Kwan-Yeung Wong, Raymond Liang, Chi-Chiu So, Yanting Qi, Dong-Yan Jin, Joseph F. Costello, Chor-Sang Chim. Br J Haematol. Sep; 154(5): 569-78. (IF: 4.959)
  43. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification. Bing Zou, C.S. Chim, Roberta Pang , Hui Zeng, Yun Dai, Rongxin Zhang, Colin S.C. Lam, Victoria P.Y. Tan, Ivan F.N. Hung, Huiyao Lan, Benjamin C.Y. Wong. Mol Carcinog. 2012 May;51(5):422-32. (IF: 4.77)
  44. Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results. Gill H, Chim CS, Au WY, Loong F, Tse E, Leung AY, Kwong YL. Ann Hematol. 2011 Apr 8. (IF: 2.396)
  45. Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies. KY Wong, CC So, F Loong, LP Chung, WWL Lam, R Liang, DY Jin, CS Chim. PloS ONE. 2011 Apr 22;6(4):e19027. (IF: 3.534)
  46. Epigenetic inactivation of the miR-203 in haematological malignancies. Chim CS, Wong KY, Leung CY, Chung LP, Hui PK, Chan SY, Yu L. J Cell Mol Med, 2011 Dec;15(12):2760-7. (IF: 3.698)
  47. Factors affecting mesenchymal stromal cells yield from bone marrow aspiration. Li J1, Wong WH, Chan S, Chim JCS, Cheung KM, Lee TL, Au WY, Ha SY, Lie AK, Lau YL, Liang RH, Chan GC. Chin J Cancer Res. 2011 Mar;23(1):43-8. (IF: 0.932)
  48. Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidlomide/dexamethasone in transplant eligible patients. Chim CS. J Transl Med. 2010; 8: 124. (IF: 3.991)
  49. DNA methylation of tumor suppressor microRNA genes: a lesson from miR-34 family. Wong KY, Yu L, Chim CS. Epigenomics. February 2011; 3(1): 83-92. (IF: 5.215)
  50. Multiple Myeloma Presenting as Interstitial Lung Disease. Ma ATW, Lo R, Cheng S, Chim CS. J Clin Oncol. 2011 Feb 20;29(6):e143-4. (IF: 17.879)
  51. Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms. Chim CS, Wan TS, Fung TK, Wong KF. J Clin Pathol.2010; 63(10):942-6. (IF: 2.551)
  52. A staged approach with vincristine, adriamycin and dexamethasone followed by bortezomib, thalidomide and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. Chim CS, Lie AKW, Chan EYT1, Leung YY1, Cheung SCW2, Chan SYT, Liang R, Kwong YL. Annals Hematol. 2010 Oct; 89(10): 1019-27. (IF: 2.396)
  53. CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation. Hu XT, Chen YW Chen, Liang CT, Au WY, Wong KY, Wan SK, Wong LY, Shen L, Chan KK, Guo T, Chu KM, Tao Q, Chim CS, Loong F, Choi WL, Lu L, So CC, Chan LC, Kwong YL, Liang R, Srivastava1 G. Blood. 2010; 115(12):2458-61. (IF: 9.775)
  54. Epigenetic inactivation of the miR-34a in hematological malignancies. CS Chim, KY Wong, Y Qi, Loong F, WL Lam, LG Wong, Jin DY, Costello JF, Liang R. Carcinogenesis. 2010; 31(4):745-50. (IF: 5.266)
  55. Methylation of cyclin-dependent kinase inhibitors, XAF1, JUNB, CDH13 and soluble Wnt inhibitors in Essential Thrombocythemia. Chim CS, Fung TK, Liang R. J Clin Pathol. 2010; Jun; 63(6): 518-21. (IF: 2.551)
  56. Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients. Chim CS, Sim JP, Chan CC, Kho BC, Chan JC, Wong LG, Law M, Liang R, Kwong YL. Haematology. 2010 Aug; 15(4): 187-92. (IF: 1.189)
  57. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M,Davies F, Blad J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S. Leukemia, 2009 Oct;23(10):1716-30. (IF: 9.379; international myeloma working group advisory board member)
  58. Restoration of Chemosensitivity by Bortezomib: Implication for Refractory Myeloma. Chim CS, Hwang YY, Pang C, Shek TW. Nat Rev Clin Oncol. 2009 Apr; 6(4):237-40. (IF: 15.696)
  59. Gene Hypermethylation in Multiple Myeloma : Lessons from a Cancer Pathway Approach. Chim CS, Kwong YL, Liang R. Clinical Lymphoma Myeloma. 2008 Dec;8(6):331-9. (IF: 1.929)
  60. Epigenetic Dysregulation of the Wnt Signaling Pathway in Chronic Lymphocytic Leukemia (CLL) Chim CS, Pang R, Liang R
    J Clin Pathol. 2008 Nov;61(11):1214-9. (IF: 2.551)
  61. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias. Chim CS, Chan WWL, Kwong YL. J Clin Pathol. 2008 Jul;61(7):844-7. (IF: 2.551)
  62. Rapid complete remission in multiple myeloma with Bortezomib / thalidomide / dexamethasone combination therapy following development of tumor lysis syndrome. Chim CS. Cancer Chemotherapy and Pharmacology, 2008 Jun; 62(1):181-2. (IF: 2.571)
  63. Multiple myeloma with testicular involvement Chim CS, Hwang YY, Shek TW. J Clin Oncol; 2008 Mar 20; 26(9):1558-9 (IF: 17.879)
  64. Pulmonary interstitial amyloidosis complicating multiple myeloma Chim CS, Wong M, Fan YS J Clin Oncol, 2008 Jan 20; 26(3):504-6. (IF: 17.879)
  65. Breast and pelvic masses in a myeloma patient. Hwang YY, Chim CS, Chan G, Loong F, Yau T. Ann Hematol. 87(12):1027-9, 2008. (IF: 2.396)
  66. Frequent epigenetic inactivation of the Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS, Wong KY, Loong F, WW Lam, Srivastava G. Human Pathol. 2007 Dec;38(12):1849-57. (IF: 2.806)
  67. Epigenetic Dysregulation of Wnt Signaling Pathway in Multiple Myeloma. Chim CS, R Pang, TK Fung , CL Choi , R Liang. Leukemia. 2007 Dec;21(12):2527-36. (IF: 9.379)
  68. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS, Lie AKW, Liang R, Au WY, Kwong YL. Bone Marrow Transplantation, 2007 Aug;40(4):339-47. (IF: 3.466)
  69. Fine needle aspiration cytology of folliclar dendritic cell sarcoma: a report of two cases and review of literature. Fan YS, Ng WK, Chan A, Chan GSW, Tsang J, Chim CS, Ip P. Acta Cytologica, 2007, Jul-Aug; 51(4):642-7. (IF: 1.562)
  70. Epigenetic dysregulation of the death-associated protein kinase / p14 / HDM2 / p53 /Apaf-1 apoptosis pathway in multiple myeloma. Chim CS, Liang R, Fung TK, Choi CL, Kwong YL. J Clin Pathol. 2007 Jun; 60(6): 664-9. (IF: 2.551)
  71. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma. Chim CS, Liang R, Leung MH, Kwong YL. J Clin Pathol. 2007 Jan; 60(1):104-6. (IF: 2.551)
  72. Pathological bone fracture in non-Hodgkin's lymphoma. Chim CS, Yiu CP, Shek TW. J Clin Oncol, 25(21):3175-6, 2007. (IF: 17.879)
  73. Use of Fludarabine-Containing Chemotherapeutic Regimen Results in Durable Complete Remission of Subcutaneous Panniculitis-Like T-Cell Lymphoma. Chim CS, Loong F, Ng WK, Kwong YL. Am J Clin Dermatol, 9 (6): 396-398, 2008. (IF: 2.519)
  74. Deafness associated with the use of Bortezomib in Multiple Myeloma Chim CS, Wong LG. Acta Oncologica, 2007 Aug 29:1-2 (IF: 3.71)
  75. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC. Gastroenterology. 2006 Dec;131(6):1835-43. (IF: 13.926)
  76. Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia. Chim CS, Fung TK, Wong KF, Lau JS, Liang R. Leuk Res. 2006 Sep; 30(9):1135-9. (IF: 2.692)
  77. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. Chim CS, Fung TK, Wong KF, Lau JS, Law M, Liang R. J Clin Pathol. 2006 Sep; 59(9): 921-6. (IF: 2.551)
  78. Aberrant gene promoter methylation marking disease progression in multiple myeloma. Chim CS, Liang R, Leung MH, Yip SF, Kwong YL. Leukemia. 2006 Jun; 20(6): 1190-2. (IF: 9.379)
  79. Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor. Chim CS, Chan WW, Pang A, Kwong YL. Leukemia. 2006 May; 20(5): 907-9. (IF: 9.379)
  80. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia. Chim CS, Kwong YL. Leuk Lymphoma. 2006 May; 47(5):815-25. Review. (IF: 2.605)
  81. CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia. Chim CS, Lau JS, Wong KF, Kwong YL. Leukemia. 2006 Jan;20(1):149-51. (IF: 9.379)
  82. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia. Chim CS, Fung TK, Wong KF, Lau JS, Liang R. J Hum Genet. 2006; 51(9):832-8. (IF: 2.526)
  83. Primary large B-cell lymphoma of the ampulla of Vater. Chim CS, Yuen WK, Loong FL, Hu WH, Ooi GC. Haematologica, 2006; 91(3): ECR06. (IF: 5.868)
  84. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment. Chim CS, Pang YY, Ooi GC, Shek TW. Haematologica, 2006; 91(8 Suppl): ECR31. (IF: 5.868)
  85. Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas. Ooi GC, Chim JCS, Au WY, Khong PL. AJR Am J Roentgenol 2006; 186(3): 821-7. (IF: 2.744)
  86. Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease. Chan JCW, Chim CS, Ooi GC, Cheung B, Liang R, Chan TK, Chan V. Br J Haematol; 133(2): 198-205, 2006 (IF: 4.959)
  87. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Chim CS, Wong SY, Pang A, Chu P, Lau JS, Wong KF, Kwong YL. Leukemia. 2005 Dec;19(12):2241-6. (IF: 9.379)
  88. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Chim CS, Wong AS, Kwong YL. Am J Hematol. 2005 Dec; 80(4): 282-7. (IF: 3.477)
  89. Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide. Au WY, Fung AT, Ma ES, Chan CH, Wong KF, Chim CS, Liang RH, Kwong YL. Br J Haematol. 2005 Dec; 131(5): 632-5. (IF: 4.959)
  90. Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma. Chim CS, Liang R, Fung TK, Kwong YL. Leukemia. 2005 Dec; 19(12): 2352-5. (IF: 9.379)
  91. Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia treated with fludarabine : case report and review of literature. Leung YH, Tsang W, Chim CS. Am J Haematol. 2005 Jul;79(3):246-7. (IF: 3.477)
  92. A long-term follow-up study on hepatitis B surface antigen positive patients undergoing allogeneic hematopoietic stem cell transplantation. Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, Zhang HY, Chim CS, Kwong YL, Liang R, Lau GK. Blood. 2005 Jul 15;106(2):464-9. 2005 (IF: 9.775)
  93. Absence of ATM hypermethylation in mantle cell and follicular lymphoma. Chim CS, Wong KY, Loong F, Srivastava G. Leukemia. 2005 May; 19(5): 880-2. (IF: 9.379) (IF: 8.634; citation: 7; contribution: 90%; 1st and corresponding author)
  94. Der(8)t(1;8) in myeloblastic transformation of ET with hydroxyurea as the sole prior treatment. Chim CS, Ma SK. Hematol Oncol. 2005; 23(2): 57-60. (IF: 4.933)
  95. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Au WY, Ma SY, Chim CS, Choy C, Loong F, Lie AK, Lam CC, Leung AY, Tse E, Yau CC, Liang R, Kwong YL. Ann Oncol 2005; 16: 206-14. (IF: 6.578)
  96. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. Chim CS, Ma SK Loong F, Kwong YL. J Clin Pathol; 58(4): 443-5, 2005. (IF: 2.551)
  97. Primary Anaplastic Large Cell Lymphoma of the Pancreas. Chim CS, Ho J, Ooi GC, Choy C, Liang R. Leukemia & Lymphoma; 46(3): 457-9.2005. (IF: 2.605)
  98. Primary gastrointestinal lymphoma of the Colon. Chim CS, Shek TW. Haematologica Nov; 90 Suppl: EIM01, 2005. (IF: 5.868)
  99. Bortezomib in refractory primary plasmacytoma. Chim CS, Loong F, Ooi C, Au AWM, Lie AKW. J Clin Oncol 2005; 23(10): 2426-8. (IF: 17.879)
  100. Extramedullary cardiac plasmacytoma presenting with cardiac tamponade. Chim CS, Loong F, Ma SK, Ooi GC. J Clin Oncol; 23(13): 3140-3, 2005. (IF: 17.879)
  101. Bulbar palsy in multiple myeloma. Chim CS, Ooi GC.Haematologica, 2005; 90(12 Suppl): ECR42. (IF: 5.868)
  102. Long-term outcome of 231 patients with Essential Thrombocythemia: Prognostic factors for bleeding, thrombosis, myelofibrosis and leukaemia. Chim CS, Kwong YL, Lie AKW, Ma SK, Chan CC, Wong LG, Kho BCS, Lee HK, Sim JPY, Chan CH, Chan JCW, Yeung YM, Law M, Liang R. Arch Intern Med 2005; 165: 2651-2658. (IF: 13.246)
  103. Eosinophilic leukemic transformation in polycythemia rubra vera. Chim CS, Ma SK. Leukemia & Lymphoma, 127: 607-611, 2005. (IF: 2.605)
  104. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. Au WY, Lam CCK, Chim CS, Pang AWK, Kwong YL. Leukemia Research 2005; 29: 1213-1215. (IF: 2.692)
  105. Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. Hui CK, Bowden S, Jackson K, Au WY, Fong DY, Lie AK, Chim CS, Liang R, Lau GK. Blood; 105(6): 2616-7, 2005. (IF: 9.775)
  106. Effectiveness of Prophylactic Anti-HBV Therapy in Allogeneic Hematopoietic Stem Cell Transplantation with HBsAg Positive Donors. Hui CK, Lie A, Au WY, Ma SY, Leung YH, Zhang HY, Sun J, Cheung WW, Chim CS, Kwong YL, Liang R, Lau GK. Am J Transplant 2005; 5(6): 1437-45. (IF: 6.19)
  107. An epidemiological study of motor neuron disease in Hong Kong. Fong GC, Cheng TS, Lam K, Cheng WK, Mok KY, Cheung CM, Chim CS, Mak W, Chan KH, Tsang KL, Kwan MC, Tsoi TH, Cheung RT, Ho SL. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6(3): 164-8. (IF: 2.591)
  108. How frequent is SOCS1 methylation in acute myeloid leukaemia? Chim CS, Kwong YL. Br J Haematol. 2004 Dec;127(5):609-11. (IF: 4.959)
  109. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.Chim CS, Wong AS, Kwong YL. Ann Hematol. 2004 Aug; 83(8): 527-32. (IF: 2.396)
  110. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.Au WY, Pang A, Choy C, Chim CS, Kwong YL. Blood 2004 Jul 1;104(1):243-9. (IF: 9.775)
  111. Concurrent hyperreactive malarial splenomegaly and quartan malarial nephropathy - Plasmodium malariae revisited. Chim CS, Wong SSY, Poon T, Lam CCK, Chan KW. Haematologica. 2004 Jul; 89(7):ECR21. (IF: 5.868)
  112. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.Chim CS, Fung TK, Cheung WC, Liang R, Kwong YL. Blood. 2004 Jun 15;103(12):4630-5. (IF: 9.775)
  113. Bull's neck in Hodgkin's disease: a CT imaging appraisal.Chim CS, Ooi GC. Haematologica, 2004 May 01;89(5):EIM11. (IF: 5.868)
  114. Methylation profiling in multiple myeloma.Chim CS, Kwong YL, Fung TK, Liang R. Leuk Res. 2004 Apr; 28(4):379-85. (IF: 2.692)
  115. Absence of p300 gene promoter methylation in acute leukemia.Chim CS, Wong AS, Kwong YL. Cancer Genet Cytogenet (Cancer Genetics). 2004 Apr 15; 150(2): 164-7. (IF: 2.417)
  116. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway.Chim CS, Wong KY, Loong F, Srivastava G. Leukemia. 2004 Feb; 18(2): 356-8. (IF: 9.379)
  117. FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.Au WY, Fung A, Chim CS, Lie AK, Liang R, Ma ESK, Chan CH, Wong KF, Kwong YL. Br J Haematol, 125: 463-469, 2004. (IF: 4.959)
  118. Primary Granulocytic Sarcoma of the Mediastinum Wong WS, Loong F, Ooi GC, Tse TC, Chim CS Leuk Lymphoma; 45(9):1931-1933, 2004. (IF: 2.605)
  119. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.Chim CS, Ma SK, Au WY, Choy C, Lie AKW, Yau CC, Liang R, Kwong YL. Blood, 103: 216-221, 2004. (IF: 9.775)
  120. Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients.Ma SY, Au WY, Chim CS, Lie AK, Lam CC, Tse E, Leung AY, Liang R, Kwong YL. Br J Haematol 2004; 124(6): 754-61. (IF: 4.959)
  121. Mucosa-associated lymphoid tissue (MALT) lymphoma of the jejunum: an elusive cause of recurrent upper gastrointestinal bleeding. Chim CS, Loong F, Chu KM, Ooi GC. Leukemia & Lymphoma; 45(2): 405-7, 2004. (IF: 2.605)
  122. Primary Follicular Lymphoma of the Small Intestine.Chim CS, Loong F, Leung AY, Tsang J, Ooi GC. Leukemia & Lymphoma; 18(2): 356-8, 2004. (IF: 2.605)
  123. Magnetic Resonance (MR) Imaging of Leptomeningeal Lymphoma Chim CS, Ma ESK, Ooi GC Br J Haematol; 124(5): 566, 2004. (IF: 4.959)
  124. Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma. Ma SY, Lie AK, Au WY, Chim CS, Kwong YL, Liang R. Hong Kong Med J 2004; 10(2): 77-83.
  125. Solitary bone plasmacytoma: role of magnetic resonance imaging and positron emission tomography. Chim CS, Ooi GC, Loong F, Liang R. J Clin Oncol, 22: 1328-30, 2004. (IF: 17.879)
  126. Cast nephropathy in Multiple Myeloma. Chim CS, Li FK, Chan G. Haematologica; 89(4): EIM08, 2004. (IF: 5.868)
  127. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.Chim CS, Wong AS, Kwong YL. Ann Hematol. 2003 Dec;82(12):738-42. (IF: 2.396)
  128. Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS. Chim CS, Fung TK, Liang R. Leukemia. 2003 Dec;17(12):2533-5. (IF: 9.379)
  129. Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance. Chim CS, Wong SY, Kwong YL. Br J Haematol. 2003 Aug;122(4):571-8. (IF: 4.959)
  130. Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia. Au WY, Lie AK, Chim CS, Liang R, Ma SK, Chan CH, Mak YK, Chen YT, So CC, Yeung YM, Yip SF, Wong LG, Chan JC, Liu SY, Kwong YL. Ann Oncol; 14(5): 752-7, 2003. (IF: 6.578)
  131. Multiple lymphomatous polyposis in lymphoma of colon Chim CS, Shek TWH, Liang R J Clin Oncol; 21: 953-955, 2003. (IF: 17.879)
  132. Mantle cell lymphoma of the prostate gland Chim CS, Yau T, Loong F, Liang R. J Clin Oncol; 21: 4456-4458, 2003. (IF: 17.879)
  133. Gastrointestinal Manifestations in Mantle Cell Lymphoma Chim CS, Wayne Wu, Loong F, Ooi GC, Liang R. Gastrointest Endosc; 58(6): 931-3, 2003. (IF: 4.9)
  134. Further analysis of clonality in Kimura’s disease. Chim CS, Liang R, Fung A, Shek TW, Kwong YL. Am J Surg Pathol, 27: 703-704, 2003 (IF: 4.592)
  135. Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease? Chan V, Wong MS, Ooi C, Chen FE, Chim CS, Liang RH, Todd D, Chan TK. Blood Cells Mol Dis; 30: 107-11, 2003. (IF: 2.331)
  136. Electronic clinical practice guidelines: current status and future prospects in Hong Kong. Chim CS, Cheung NT, Wong KC, Hong F. Hong Kong Med J; 9: 299-301, 2003.
  137. Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia. Chim CS, Wong AS, Kwong YL. Br J Haematol. 2002 Dec;119(4):988-90. (IF: 4.959)
  138. Hypermethylation of gene promoters in hematological neoplasia. Chim CS, Liang R, Kwong YL. Hematol Oncol. 2002 Dec;20(4):167-76. Review. (IF: 4.933)
  139. Real-time quantification of the multidrug resistance-1 gene expression in relapsed acute promyelocytic leukemia treated with arsenic trioxide. Au WY, Chim CS, Wai Lie AK, Pang A, Kwong YL. Haematologica; 87(10):1109-11, 2002. (IF: 5.868)
  140. Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide. Au WY, Chim CS, Lie AK, Liang R, Kwong YL. Br J Haematol; 117: 130-132, 2002. (IF: 4.959)
  141. Atypical blasts and bone marrow necrosis associated with near-triploid relapse of acute promyelocytic leukemia after arsenic trioxide treatment. Chim CS, Lam C, Wong KF, Cornelia Wong, Kam S, Kwong YL. Hum Pathol; 33(8): 849-51, 2002. (IF: 2.806)
  142. Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease. Au WY, Ma SK, Chung LP, Chim CS, Kwong YL. Ann Hematol; 81: 659-661, 2002. (IF: 2.396)
  143. Acute biphenotypic leukaemia Chim CS, Ma SK Haematologica; 87(1): EIM03, 2002. (IF: 5.868)
  144. Vision-threatening complications of nasal T/NK lymphoma. Hon C, Kwok AK, Shek TW, Chim JC, Au WY. Am J Ophthalmol; 134: 406, 2002. (IF: 4.021)
  145. CNS involvement in CD56-positive intestinal gamma/delta T-cell lymphoma. Chim CS, Lam CCK, Nicholls J, Ooi GC, Kwong YL. J Clin Oncol; 20: 3742-3744, 2002. (IF: 17.879)
  146. Primary natural killer cell lymphoma of skeletal muscle. Chim CS, Au WY, Loong F, Ooi GC, Poon C, Choy C, Kwong YL. Histopathology; 41: 371-4, 2002. (IF: 3.301)
  147. Primary skeletal muscle lymphoma. Chim CS, Choy C, Ooi GC, Gopesh G, Liang R Am J Med; 112(1): 79-80, 2002. (IF: 5.302)
  148. Primary MALT lymphoma of the Gallbladder. Chim CS, Liang R, Loong F, Chung LP Am J Med; 112(6): 505-507, 2002. (IF: 5.302)
  149. Gut perforation in MALToma of colon. Chim CS, Shek TWH, Chung LP, Ho J Haematologica; 87(4): EIM15, 2002. (IF: 5.868)
  150. Intravascular lymphomatosis of the prostate gland. Chim CS, Loong F. Br J Haematol, 119: 2, 2002. (IF: 4.959)
  151. Hemorrhagic Gastric Plasmacytoma as the Primary Presentation in Multiple Myeloma Chim CS, Wong WM, Nicholls J, Chung LP, Liang R. J Clin Oncol; 20: 344-347, 2002. (IF: 17.879)
  152. Analysis of Clonality in Kimura's Disease.Chim CS, Alvin, Liang R, Shek TWH, Ho WK, Kwong YL Am Surg Pathol J; 26(8): 1083-6, 2002. (IF: 4.592)
  153. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. Leung AY, Chim CS, Ho PL, Cheng CC, Yuen KY, Lie AK, Au WY, Liang R, Kwong YL. J Hosp Infect; 50: 316-319, 2002. (IF: 2.782)
  154. Diagnosis by death. Tang S, Chim CS, Lai KN. Ann Intern Med; 137(6): 552-3, 2002. (IF: 16.104)
  155. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Chim CS, Tam CY, Liang R, Kwong YL. Cancer. 2001 Jun 15;91(12):2222-9. (IF: 4.901)
  156. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. Chim CS, Liang R, Tam CY, Kwong YL. J Clin Oncol. 2001 Apr 1;19(7):2033-40. (IF: 17.879)
  157. Arsenic trioxide and idarubicin induced remission in relapsed acute promyelocytic leukemia: clinicopathological and molecular features of a pilot study. Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R Am J Hematol; 66 (4): 274-9, 2001. (IF: 3.477)
  158. Radiologic manifestations of granulocytic sarcoma in adult leukemia. Ooi GC, Chim CS, Khong PL, Au WY, Lie AKW, Tsang KWT, Liang R. Am J Roentol, 176: 1427-1431, 2001. (IF: 2.744)
  159. External auditory canal tumor in acute promyelocytic leukaemia: a rare chloroma with a complete response to arsenic trioxide. Au WY, CF Chan, Chim CS, Shek TW, Ooi GC, Ho WK, Kwong YL. J Clin Oncol; 19: 3993-3995, 2001. (IF: 17.879)
  160. Chronic Lymphocytic Leukemia involving the Gallbladder. Chim CS, Loong F, Chung LP Br J Haematol, 115:717, 2001. (IF: 4.959)
  161. Leptomeningeal leukemia masquerading as cauda equina syndrome: appraisal by magnetic resonance imaging. Chim CS, Ooi GC. Haematologica; 86: 1117, 2001. (IF: 5.868)
  162. Cerebral Leukostasis manifesting as Multifocal Intracerebral Haemorrhage Chim CS, Ooi GC Haematologica; 86: 1231, 2001. (IF: 5.868)
  163. Primary CD56 positive lymphomas of the gastrointestinal tract. Chim CS, Shek TW, Ho J, Liang R, Kwong YL
    Cancer, 91:525-533, 2001. (IF: 4.901)
  164. Sclerosing malignant lymphoma mimicking idiopathic retroperitoneal fibrosis: importance of clonality study. Chim CS, Chan AC, Liang R Am J Med, 111: 240-241, 2001. (IF: 5.302)
  165. Primary Hepatic Lymphoma Chim CS, Choy C, Ooi GC, Liang R Leukemia & Lymphoma, 40: 667-670, 2001 (IF: 2.605)
  166. Muscle Lymphoma Chim CS, Au WY, Ooi GC. Lancet, 357: 132, 2001. (IF: 39.207)
  167. B-cell Lymphoma of the Gallbladder Chim CS, Ooi GC Haematologica; 86: 1119, 2001. (IF: 5.868)
  168. Primary Extamedullary Plasmacytoma (EMP) of the lacrimal gland. Chim CS, Ng IOL, Trendell-Smith NJ, Liang R Leukemia and Lymphoma, 42: 831-834, 2001. (IF: 2.605)
  169. Clinicopathologic and prognostic features of chronic idiopathic thrombocytopenic purpura in adult chinese patients-an analysis of 220 cases. Leung YH, Chim CS, Kwong YL, Lie AKW, Au WY, Liang RHS. Annals of Haematol, 80(7): 384-386, 2001. (IF: 2.396)
  170. Genetic analysis of HLA-typing in Chinese patients with idiopathic thrombocytopenic purpura (ITP). Leung AYH, Hawkins BR, Chim CS, Kwong YL, Liang R. Haematologica 86: 221, 2001. (IF: 5.868)
  171. Splenic rupture as the presenting symptom of blastic crisis in a patient with Philadelphia-negative, bcr-abl-positive ET. Chim CS, Shek TW, Ma SK, Kwong YL Am J Haematol, 66: 70-71, 2001. (IF: 3.477)
  172. Hemighost cell in acute hepatitis A: glucose-6-phosphate deficiency revisited. Chim CS, Lam CC, Chan TK Am J Med, 111: 81-2, 2001. (IF: 5.302)
  173. Absence of gallium uptake in multicentric Castleman's disease of plasma cell type. Chim CS, Choy PT, Kwong YL Haematologica, 86: 442-443, 2001. (IF: 5.868)
  174. Serous degeneration of the bone marrow Chim CS, Ma SK Haematologica, 86: 558, 2001. (IF: 5.868)
  175. Primary malignant ocular melanoma: a bone marrow diagnosis. Chim CS, Trendall-smith NJ Br J Haematol, 112: 2, 2001. (IF: 4.959)
  176. CD-30 positive peripheral T-cell lymphoma of the Waldeyer's ring. Chim CS, Shek WH, Ooi GC, Liang R Leukemia and Lymphoma. 2000 Jun; 38(1-2):199-202. (IF: 2.605)
  177. Nasal T-cell/natural killer cell lymphoma: CT and MR Imaging features of a new clinicopathologic entity. Ooi GC, Chim CS, Liang R, Tsang KWT, Kwong YL AJR American Journal of Roentgenology. 174:1141-5, 2000. (IF: 2.744)
  178. Meningeal relapse in Hodgkin’s disease Chim CS, Shek TWH, Ooi GC, Liang R Journal of Clinical Oncology, 18: 1153-1155, 2000. (IF: 17.879)
  179. Pulmonary intravascular lymphomatosis.Chim CS, Choy C, Ooi GC, Chung LP, Wong KK, Liang R. J Clin Oncol; 18: 3733-3735, 2000. (IF: 17.879)
  180. Hodgkin's Disease with Primary Manifestation in the Liver. Chim CS, Choy C, Liang R Leukemia & Lymphoma; 37(5-6): 629-632, 2000. (IF: 2.605)
  181. Giant pronormoblasts in parvovirus-associated pure red cell aplasia Chim CS, Ma SK Am J Hematol; 65 (4): 289, 2000. (IF: 3.477)
  182. Isolated splenic tuberculosis presenting with pyrexia of unknown origin. Ho PL, Chim CS, Yuen KY Scand J Infect Dis 32: 700-701, 2000. (IF: 1.64)
  183. Treatment of de novo acute myeloid leukaemia in Hong Kong: a twenty-year experience (1975 to 1996).. Chim CS, Liang R, Kwong YL, Lie AKW, Todd D, Chan TK Aust N Z J Med (Internal Medicine Journal), 25: 726-730, 1999. (IF: 1.699)
  184. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT). Lee CK, Lie AKW, Liang R, Au WY, Chen FE, Chim CS, Kwong YL Am. J. Hematol. 61:85-89, 1999. (IF: 3.477)
  185. Complex variant 15; 17 translocations in acute promyelocytic leukemia: a case report and review of three-way translocations. Wan TSK, Chim CS, So CK, Chan LC, Ma SK Cancer, Genetics & Cytogenetics (Cancer Genetics); 111(2): 139-431, 1999. (IF: 2.417)
  186. Isolated relapse of acute lymphoblastic leukemia in the breast masquerading as gynecomastia Chim CS, Shek WH, Liang R
    American Journal of Medicine, 108: 677-679, 1999. (IF: 5.302)
  187. Bone Marrow Necrosis Masquerading as Interferon Toxicity in Chronic Myeloid Leukemia. Chim CS, Ma Sk, Lam CK Leukemia and Lymphoma, 33(3-4): 385-388, 1999. (IF: 2.605)
  188. Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience Chim CS, Kwong YL, Lie KW, Lee CK, HO FCS, Liang R American Journal of Hematology, 61 (3), 159-163, 1999. (IF: 3.477)
  189. CEOP treatment results and validity of the international index in Chinese patients with aggressive non-Hodgkin's lymphoma. Chim CS, Kwong YL, Lie AK, Lee CK, Liang Raymond Hematol Oncol, 16: 117-123, 1999. (IF: 2.355)
  190. Computed tomography features of primary pulmonary non-Hodgkin's lymphoma GC Ooi, Chim CS, Chen F, A Lie, KWT Tsang
    Clinical Radiology; 54(7): 438-443, 1999. (IF: 1.663)
  191. Lethal Midline Granuloma Revisited: Nasal T/NK cell lymphoma Chim CS, Ooi GC, Shek WH, Liang R, Kwong YL Journal of Clinical Oncology, 17: 1322-1325, 1999. (IF: 17.879)
  192. Signet Ring Lymphoma of the Bone Marrow Chim CS, Ma SK, Lam CK, Liang R J Clin Oncol, 17: 728-729, 1999. (IF: 17.879)
  193. Primary follicle center (FCL) lymphoma of the colon. Chim CS, Choy C, Ooi GC, Liang R. J Clin Oncol, 17: 3684-3688, 1999. (IF: 17.879)
  194. Primary anaplastic large cell lymphoma of skeletal muscle presenting with compartment syndrome. Chim CS, Choy C, Liang R
    Leukemia and Lymphoma, 33(5-6): 601-605, 1999 (IF: 2.605)
  195. Isolated Uterine relapse of T/NK cell lymphoma Chim CS, Choy C, Liang R, Kwong YL Leukemia & Lymphoma, 34 (5-6), 629-632, 1999. (IF: 2.605)
  196. Kimura’s disease: No evidence of clonality Chim CS, Shek CC, Liang R, Kwong YL Br J Ophthamol, 83; 878-9, 1999. (IF: 2.809)
  197. Castleman’s disease with Kaposi’s sarcoma and glomerulonephritis Chim CS, Lam KY, Chan KW American Journal of Medicine, 107: 186-188, 1999. (IF: 5.302)
  198. Cryptococcal infection after fludarabine treatment Chim CS, Wong SS, Liang R, Yuen KY American Journal of Medicine, 108: 523-524, 1999. (IF: 5.302)
  199. Herpes simplex encephalitis in multiple myeloma. Chim CS, Ho PL, Yuen KY, JSM Pieres Aust N J Med (Internal Medicine Journal, 29:381, 1999. (IF: 1.699)
  200. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experience. Au WY, Lie AKW, Ma ESK, Chan LC, Lee CK, Kwong YL, Chim CS, Chan TK, Chiu E, Liang R. Hematological Oncology, 16: 163-168, 1998. (IF: 2.355)
  201. Mantle Cell Lymphoma in Chinese: clinicopathological features and treatment outcome. Chim CS, Choo CK, Chan ACL, Kwong YL, Lie A, Liang Raymond. American Journal of Hematology, 59: 295-301, 1998. (IF: 3.477)
  202. Primary CD30-positive anaplastic large cell lymphoma of the lip. Chim CS, Chan ACL, Liang Raymond. European Journal of Cancer. Oral Oncology, 34: 313-315, 1998. (IF: 3.029)
  203. Allogeneic bone marrow transplantation for severe aplastic anaemia: the Hong Kong scenario. Au WY, Lie AKW, Kwong YL, Chan TK, Chim CS, Lee CK, Chiu EKW, Liang R Hematological Oncology 16: 41-46, 1998. (IF: 2.355)
  204. Bone marrow necrosis in bone marrow transplantation: role of MR imaging. Chim CS, Ooi C, Ma SK, Lam CK. Bone Marrow Transplantation , 22: 1125-28, 1998. (IF: 3.466)
  205. Hemophilia B in a female carrier due to skewed inactivation of the normal x-chromosome. Chan V, Chan VWY, Yip B, Chim CS, Chan TK. American Journal of Hematology, 58: 72-76, 1998. (IF: 3.477)
  206. Reactive Hemophagocytic Syndrome associated with Penicillium marneffei infection. Chim CS, Fong CY, Ma SK, Wong CY, Yuen KY. American Journal of Medicine, 104, 196-7, 1998. (IF: 5.302)
  207. Fungal Endocarditis in Bone Marrow Transplantation : Case Report and Review of Literature Chim CS, Ho PL, Yuen ST, Yuen KY Journal of Infection, 37: 287-304, 1998. (IF: 4.017)
  208. Simultaneous Herpes simplex and Aspergillus fischeri pneumonia in a patient with multiple myeloma. Chim CS, Ho PL, Yuen KY. Scandinavian Journal of Infectious Disease 30: 190-191, 1998. (IF: 1.64)
  209. Molecular detection of minimal residual disease in adult and childhood ALL reveals differences in treatment responses. Foroni L, Coyle LA, Papaioannou M, Yaxley JC, Sinclair MF, Chim JS, Cannell P, Secker-Walker LM, Mehta AB, Prentice HG, Hoffbrand AV. Leukemia, 1997, 11: 1732-1741 (IF: 9.379)
  210. Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary report. Chim CS, Kwong YL, Chu YC, Chan CH, Chan YT, Liang R. Hematological Oncology, 15 : 19-26, 1997. (IF: 2.355)
  211. Deafness in chronic myeloid leukemia. Chim CS, Woo John. Leukemia and Lymphoma , 26 : 209-10, 1997. (IF: 2.605)
  212. Primary B cell lymphoma of the mediastinum. Chim CS, Liang Raymond, Chan ACL, Kwong YL, Ho FCS, Todd David. Hematological Oncology, 14 : 173-9, 1997. (IF: 2.355)
  213. Primary cardiac lymphoma. Chim CS, Chan ACL, Kwong YL, Liang R. American Journal of Hematology, 54 ; 79-83 : 1997. (IF: 3.477)
  214. CD56+ NK lymphomas: clinicopathological features and prognosis. Kwong YL, Chan ACL, Liang R, Chiang AKS, Chim CS, Chan TK, Todd D, Ho FCS. British Journal of Haematology, 97: 821-829, 1997. (IF: 4.959)
  215. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma R Liang, Chen F, Lee CK, Kwong YL, Chim CS, Yau CC, Chiu E. Bone Marrow Transplantation 1997; 19 : 91-93. (IF: 3.466)
  216. Malignant lymphoma masquerading as multiple myeloma. Chim CS, Ma SK, Leung CY. Leukemia and Lymphoma, 28 : 607-611, 1997. (IF: 2.605)
  217. Reactive Haemophagocytic Syndrome and Hodgkin’s disease. Chim CS, Hui PK. American Journal of Hematology, 55 : 49-50, 1997. (IF: 3.477)
  218. Polycythemia vera in Chinese patients: thirty-six years of experience. Chim CS, Kwong YL, Chan PT, Liang Raymond. American Journal of Hematology, 56 : 59-62, 1997. (IF: 3.477)
  219. Unrelated Marrow Donor Registry for Chinese. Liang Raymond Lee CK, Chen F, Kwong YL, Chim CS, Au WY, Ha SY, ChanCF, Lau YL. Chinese Medical Journal, 110, 494-6, 1997. (IF: 1.016)
  220. Hemosiderosis with diabetes mellitus in untransfused Hemoglobin H disease. Chim CS, Chan Vivian, Todd David. American Journal of Hematology , 57 : 160-163, 1997. (IF: 3.477)
  221. Trichostrongylus infestation masquerading as conditioning toxicity of the gut in bone marrow transplantation. Chim CS, Luk WK, Yuen KY. Bone Marrow Transplantation, 19 : 955-958, 1997. (IF: 3.466)
  222. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Chim JCS, Coyle LA, Yaxley JC, Cole-Sinclair MF, Cannell PK, Hoffbrand VA, Foroni L. British Journal of Haematology, 1996 ; 92 : 104-115. (IF: 4.959)
  223. Molecular analysis of the leukemic B cell in adult and childhood acute lymphoblastic leukemia. Coyle LA, Papaioannou M, Yaxley JC, Chim JS, Attard M, Hoffbrand AV, Foroni L. British Journal of Haematology, 1996 ; 94 : 685-693. (IF: 4.959)
  224. All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Chim CS, YC Chu, YL Kwong, R Liang, CK Lee, D Todd, TK Chan. Hematological Oncology, 1996; 14 : 147-154. (IF: 2.355)
  225. Cerebellar toxicity with medium dose cytarabine in a young patient with renal insufficiency. Chim CS, Kwong YL American Journal of Hematology, 53 : 208 ; 1996. (IF: 3.477)

Conference Papers

  1. 11C-acetate PET/CT predicts 4-year overall survival for patients with newly diagnosed myeloma. The SNMMI Annual Meeting 2015, Baltimore, Maryland, June 6-10, 2015. (Abstract)
    Sirong Chen, William Cheung, Kam Chau Cheng, Yim Lung Leung, Ka-nin Wong, CS Chim*, Chi-Lai Ho* (*corresponding author)
  2. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways. 35th Congress of the International Society of Hematology, Beijing, Sep 2014. (Oral Presentation) LQ Wang, KY Wong, CS Chim
  3. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NF-kappaB pathway. 23rd Biennial Congress of the European Association for Cancer Research, Munich, Germany, Jul 2014. (poster) LQ Wang, YL Kwong, CS Kho, KF Wong, KY Wong, M Ferracin, GA Calin and CS Chim
  4. Epigenetic silencing of tumor suppressor miR-3151 in Chinese chronic lymphocytic leukemia patients. 23rd Biennial Congress of the European Association for Cancer Research, Munich, Germany, Jul 2014. (poster) LQ Wang, KY Wong, CS Chim
  5. MIR-155-3P IS A TUMOR SUPPRESSIVE MICRORNA FREQUENTLY SILENCED BY DNA METHYLATION IN MANTLE CELL LYMPHOMA & OTHER NON-HODGKIN'S LYMPHOMA. 2014 Pan Pacific Lymphoma Conference, The Fairmont Orchid, Hawaii, Jul 2014. (Abstract) Rita LH Yim, Kwan Yeung Wong, YL Kwong, Chor Sang Chim
  6. Phase 1 pharmacokinetic (PK) study of Ixazomib citrate (MLN9708) plus Lenalidomide and Dexamethasone in Asian patients with relapsed/refractory multiple myeloma (RRMM). 19th Congress of the European Hematology Association, Milan, Italy, June 2014. (Abstract)
    N Gupta, YT Goh, Chang-ki Min, JH Lee, C Suh, K Kim, R Wong, CS Chim, MJ Hanley, H Yang, K Venkatakrishnan, Ai-Min Hui, C Schusterbauer, WJ Chng
  7. Immunoglobulin oligoclonal bands and isotype switching after bone marrow transplantation in patients with multiple myeloma. 16th Congress of the European Hematology Association, June 2010 Eric Chan, Eric Kwong, WK Ip, CS Chim*
  8. A staged approach with vincristine, adriamycin and dexamethasone followed by bortezomib, thalidomide and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. Health Research Symposium 2010: Improving health and recognising excellence, Hong Kong Academy of Medicine, the Food and Health Bureau, Hong Kong, Sept 2010. (Abstract) Chim CS
  9. Epigenetic silencing of miR-203 is a disease initiation event of multiple myeloma. European Association of Cancer Research, Norway, 2010. (Poster) KY Wong, DY Jin, R Liang, and CS Chim.
  10. A staged approach with vincristine, adriamycin and dexamethasone followed by bortezomib, thalidomide and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. 15th Congress of the European Hematology Association, June 2010. (Abstract) Chim CS, Lie AKW, Liang R, Kwong YL.
  11. Epigenetic alterations of the miR-34a in hematological malignancies. 15th Congress of the European Hematology Association. June 2010. (Poster) Chim CS, Wong KY, Qi Y
  12. Epigenetic inactivation of the miR-34a in hematological malignancies. Epigenetics, Chromatin & Transcription, Suzhou, 2010. (Poster) Chim CS, Wong KY
  13. Induction with sequential Bortezomib/thalidomide/dexamethasone after VAD results in significant cytoreduction prior to BMT in multiple myeloma. XIth International Workshop on Multiple Myeloma & IVth International Workshop on Waldenstrom's Macroglobulinemia. Greece, June 2007. (Poster) Chim CS, Lie AKW, Liang R, Au WY, Kwong YL.
  14. Epigenetic Dysregulation of Wnt Signaling Pathway in Multiple Myeloma. XIth International Workshop on Multiple Myeloma & IVth International Workshop on Waldenstrom's Macroglobulinemia. Greece, June 2007. (Poster) Chim CS, Fung TK, Pang R, Choi CL, Liang R.
  15. Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukaemia: an independent poor prognostic factor. 11th Congress of the EHA, Amsterdam, Netherlands, June 2006. (Poster) Chim CS, WWL Chan, A Pang, YL Kwong.
  16. Long-term outcome of allogeneic bone marrow transplantation (BMT) for 108 adult patients with acute lymphoblastic leukaemia (ALL): favorable outcome with BMT at first remission and HLA-matched unrelated donor. 11th Congress of Asia-Pacific BMT Meeting, Nogoya, 2006. (Oral presentation) Chim CS, Lie AKW, Liang R, Au WY, Kwong YL.
  17. Deferiprone in the treatment of iron overload in patients with HbH disease. 30th World Congress of ISH 2005, Istanbul, Turkey. (Oral presentation), July 2005 TK Chan, Vivian Chan, Joyce CW Chan, Chim CS, Clara Ooi, B Cheung, RHS Liang,
  18. Epigenetic Dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 Apoptosis Pathway in Multiple Myeloma : Prognostic value of DAP Kinase methylation. 30th World Congress of ISH, Turkey, Istanbul, July 2005. (Poster) Chim CS, R Liang, Fung TK, Kwong YL. Long-term outcomes of 231 patients with Essential Thrombocythemia: Prognostic factors to bleeding, thrombosis, myelofibrosis and leukaemia. 30th World Congress of ISH, Turkey, Istanbul, July 2005. (Oral Presentation)
  19. Chim CS, Kwong YL, Lie AKW, Ma SK, Chan CC, Wong LG, Kho BCS, Lee HK, Sim JPY, Chan CH, Chan JCW, Yeung YM, Law M, Liang R.
  20. CIP/KIP methylation in multiple Myeloma. The 10th International Myeloma Workshop, Sydney, Australia, May 2005. (Poster) Chim CS, Fung TK, Liang R.
  21. Methylation if INK4 and Cip/Kip families of cyclin-dependent kinase inhibitors in CLL. The 96th Annual Scientific Meeting of American Association of Cancer Research, Los Angeles, USA, April 2005. (Poster) Chim CS, Fung TK, Liang R.
  22. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukaemia. Chromatin, Chromosomes, and Cancer Epigenetics, Waikola, Hawaii, Nov 2004. (Poster) Chim CS, Wong SY, Pang A, Chu P, Kwong YL.
  23. SOCS1 AND SHP1 hypermethlation in multiple myeloma: implications for epigenetic activation of the jak/STAT pathway. 9th EHA annual scientific Meeting, Geneva, Switzerland, 2004. (Poster) Chim CS, T.K. Fung, W.C. Cheung, R. Liang, Y.L. Kwong.
  24. Efficacy of Bortezomib in Chinese patients with Refractory Myeloma. Innovation in Cancer, Valencia, Spain, 2004. Chim CS, AKW Lie, WH Leung, YL Kwong and R Liang.
  25. MPD Advisory Board meeting, Melbourne, Australia, 2004. Chim CS, et al, Essential Thrombocythemia in Chinese: clinical features and long-term follow-up.
  26. Methylation Profiling in Multiple Myeloma. 94th Annual Meeting of the American Association for Cancer Research, Toronto, 2003. (Poster) Chim CS, Kwong YL, Fung A, Liang R.
  27. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. 45th Annual Scientific Meeting of the American Society of Hematology, San Diego, 2003 (Poster) Chim CS, Ma SK, Au WY, Choy C, Lie AKW, Yau CC, Liang R, Kwong YL.
  28. Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease? Annual Scientific Meeting of the International Society of Haematology, Seoul, 2002. Chan V, Wong MS, Ooi C, Chen FE, Chim CS, Liang RH, Todd D, Chan TK.
  29. Coinheritance of HFE and TFR2 defects in HbH disease in the Chinese. Wong MS, Chim CS, Liang RHS, Todd D, Chan TK, Chan V. 7th Medical Research Conference, University of Hong Kong, 2002.
  30. Gleb Baida, Chim CS, Helen Pomykala, Diana M. Roulston, Richard A. Larson, Olufunmilayo I. Olopade. LUN, a novel transcription factor on 9p21 Is frequently deleted in human leukaemia. Medicine, University of Chicago, Chicago, IL; Medicine, University of Hong Kong, Hong Kong, China; Pathology, University of Michigan, Ann Arbor, MI. BLOOD 98 (11): 98A-99A 412 Part 1, NOV 16, 2001
  31. Mutations of the HFE gene for hereditary hemochromatosis in Southern Chinese with iron overload. Medical research meeting, University of Hong Kong, 2001. Wong MS, Chan TK, Lam KC, Chim CS, Chan V.
  32. Genetic and clinical features of hemoglobin H disease in Chinese patients: the sequela. Chen FE, Chim CS, Ooi C, Ha SY, Todd D, Chan TK, Chan V. Medical forum, University of Hong Kong, 2001.
  33. Methylation profiling in acute leukaemia. Chim CS, Liang R, Wong AW, Kwong YL. Cancer & chromosomal organization: Epigenetics of cancer, 2001.
  34. P15 and p16 gene methylation in adult acute leukemia. Chim CS, Tam CYY, Liang R, Kwong YL. 42th Annual Meeting of the American Society of Hematology, San Francisco, 5-9th, Dec, 2000.
  35. Donor lymphocyte infusion (DLI) for leukemia relapse: a revisit. Medical Research Conference 2000, Department of Medicine, University of Hong Kong, Jan, 2000. Au WY, Lie AKW, Kwong YL, Lee CK, Chim CS, Leung YH, Liang R.
  36. ICE/BEAM chemotherapy and peripheral blood stem cell rescue for relapse after bone marrow transplantation. Au WY, Lie AKW, Lee CK, Liang R, Chim CS, Leung YH, Kwong YL. Medical Research Conference 2000, Department of Medicine, University of Hong Kong, Jan, 2000.
  37. Asenic trioxide and idarubicin induced remissions in relapsed acute promyelocytic leukemia: clinicopathological and molecular features. Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R. Medical Research Conference 2000, Department of Medicine, University of Hong Kong
  38. CT and MR imaging in nasal NK/T cell lymphoma: Lethal midline granuloma reclassified. Ooi GC, Chim CS, Liang R, Tsang KWT, Kwong YL. 7th Annual Scientific Meeting, Hong Kong College of radiologists, Oct, 1999 & Radiology 2000- Imaging, Oncology & Science: Br J Radiology, poster 702, pp72, 2000
  39. Review of the use of colony-stimulating factors in the treatment of cancer. The 6th Hong Kong International Congress of Cancer, Nov, 1999. Chim CS
  40. Treatment Outcome of Adult Acute Lymphoblastic Leukemia (ALL) in Chinese with an Intensive German Protocol. Chim CS, Liang R, Chan YT, Lie AKW, Chu YC, Chan CH, Ma SK, Wong KF, Chan LC, Lee CK, Au WY, Kwong YL. 41th Annual Meeting of the American Society of Hematology, New Orleans, 1999-11-11.
  41. Fludarabine in the treatment of low grade lymphoproliferative disorders. Kwong YL, Chim CS, Au WY, Lee CK, Lie AKW, Liang R. Medical Research Conference, Department of Medicine, University of Hong Kong, Jan, 1999
  42. Treatment for post bone marrow transplant relapse of chronic myeloid leukemia using donor buffy coat with or without interferon-AKW Lie, YL Kwong, Lee CK, Chim CS, Au WY, Cahn YET, Liang R. Medical Research Conference 1999, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  43. Minimal residual disease (MRD) in acute promyelocytic leukemia. Au WY, Lie AKW, Lee CK, Chim CS, Liang R, Kwong YL. Medical Research
  44. Conference 1999, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong. Advanced stage and unfavorable Hodgkin’s disease in Hong Kong. Chim CS, Kwong YL, Lie AKW, Lee CK, Liang R. 40th Annual Meeting of American Hematology Society, December 1998, Blood
  45. Outcome of AML patients receiving allogeneic BMT using busulphan, cyclophosphamide and total body irradiation (Bu-Cy-TBI) as conditioning regimen. Lee CK, Lie AKW, Chim CS, Au WY, Kwong YL, Liang R. 40th Annual Meeting of American Hematology Society, December 1998, Blood
  46. Natural killer cell lymphoma/leukemia: clinicopathogical features, treatment and prognosis. Kwong YL, Chan ACL, Chim CS, Lie AKW, Liang R. The fifth Hong Kong International Cancer Congress, Nov, 1998
  47. Computed tomography features of primary pulmonary non-Hodgkin’s lymphoma. Ooi CGC, Chim CS, Chen F, Lie A, Tsang KWT. Hong Kong Academy of Medicine: First International Congress, 26-29 Nov, 1998
  48. Higher incidence of bcl-6 gene hypermutations in diffuse large B-cell lymphoma of extranodal origin. Liang R, Au WY, Lee CK, Chim CS, Lie AKW, Kwong YL. 27th International Society of Haematology Congress, July 1998.
  49. Immune clearance of serum hepatitis B surface antigenaemia following allogeneic bone marrow transplantation : vaccination versus natural immunity. Liang R, Lau GKK, Au WY, Lee CK, Chim CS, Lie A, Chen F, Kwong YL. 34th Annual Meeting of the American Society of Clinical Oncology. May, 1998, abstract No. 326.
  50. BCL-6 gene rearrangement and mutations in diffuse large B-cell lymphoma (DLBCL) of nodal and extranodal origin. Liang R, Xu WS, Au WY, Fung A, Chan A, Lee CK, Chim CS, Lie AKW, Kwong YL, Srivastava G. Department Research Meeting, University of Hong Kong.
  51. Allogeneic bone marrow/stem cell transplant and hepatitis B infection. Liang R, Lau GKK, Lie A, Chen F, Au WY, Lee CK, Chim CS, Kwong YL. 5th Congress of the Asian Society of Transplantation. December 1997, No.477, p520.
  52. Allogeneic bone marrow transplantation for acute myeloid leukaemia in Hong Kong. Au WY, Lie AKW, Lee CK, Chan TK, Chiu E, Kwong YL, Chim CS, Chen FE, Liang R. 14th Asian Pacific Cancer Conference, November, 1997, No. P.8.
  53. Allogeneic bone marrow transplantation for patients with chronic myeloid leukaemia in Hong Kong. Lee CK, Lie AKW, Liang R, Chiu EKW, Chen FE, Chim CS,. 14th Asian Pacific Cancer Conference, November, 1997, No.73.4 (major author)
  54. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: the Hong Kong experience. Au WY, Lie AKW, Lee CK, Chan TK, Chiu E, Kwong YL, Chim CS, Chen FE, Liang R. 14th Asian Pacific Cancer Conference, November 1997. No. 69.7.
  55. Bone marrow transplantation and hepatitis B infection. Liang R, Lau GKK, Lie AKW, Chen F, Lee CK, Au WY, Kwong YL, Chim CS.. 14th Asian Pacific Cancer Conference, November 1997, No. 19.3. Peripheral blood stem cell harvest in Hong Kong Chinese.
  56. Au WY, Lie AKW, Chan FE, Kwong YL, Lee CK, Chim CS, Chan TK, Liang R. 5th International Blood Cell Transplantation Symposium, October, 1997.
  57. Bone Marrow Transplantation and hepatitis B infection. Liang R, Lau GKK, Chen F, Lee CK, Au WY, Kwong YL, Chim CS. 33rd annual meeting of the American Society of Clinical Oncology, May 1997, abstract No. 312.
  58. Effect of bone marrow transplantation on chronic hepatitis B infections. Liang R, Lau G, Kwong YL, Chen F, Lee CK, Chim CS. 7th International Congress on anti-cancer treatment. Feb 1997, 128 .
  59. CD56+ malignant lymphoma: identification of clinico-pathological subtypes with poor prognosis. Kwong YL, Chan ACL, Liang R, Chim CS, Chiang AKS, Chan TK, Todd D, Ho FCS. 38th Annual meeting of the American Society of Hematology. December 1996, No. 891. Blood 88: A891, 1996.
  60. Polycythaemia rubra vera in Chinese. Chim CS, Kwong YL, Chan PT, Liang R. 38th Annual Meeting of American Society of Hematology. December 1996, No. 3542. Blood 88: A3542, 1996.
  61. Bone marrow transplants using matched unrelated donor for Chinese patients with leukaemia and lymphoma. Lee CK, Liang R, Chiu E, Chen F, Kwong YL, Chim CS, Ha SY, Lau YL, Hawkins BR, Chan TK. Consensus conference on unrelated donor - bone marrow transplantation, Royal College of Physicians of Edinburgh, October 1996, P2, page 24.
  62. Chemotherapy for intermediate grade lymphoma using 4 different doxorubicin-containing regimens. Liang R, Todd D, Kwong YL, Chim CS, Lee CK, Ho FCS. Bcl-6 gene rearrangement in Hodgkin's and non-Hodgkin's lymphoma in Hong Kong Chinese.
  63. Liang R, Chan WP, Kwong YL, Chim CS, Lee CK, Todd D, Chan A, Ho FCS. 32nd Annual Meeting of the American Society of Clinical Oncology, May 1996, 1307.
  64. Autologous bone marrow transplantation for primary T-/NK-cell nasal lymphoma. Liang R, Lee CK, Chim CS. 4th International Symposium on Hematopoietic Stem Cell Transplantation, April 1996, p234.
  65. Bcl-6 gene rearrangement in Hong Kong Chinese patients with lymphoma. Liang R, Chan WP, Kwong YL, Chim CS, Lee CK, Chan A, Ho FCS. 37th Annual Meeting of American Hematology Society, December 1995. Blood 86: 3254, 1995.
  66. Absence of factor V gene mutation (1691 G to A) in Hong Kong Chinese patients with deep vein thrombosis (DVT). Lee CK, Chan WP, Liang R, Kwong YL, Chim CS, Todd D, Chan TK. 37th Annual Meeting of American Hematology Society, December 1995, Blood 86 : 3665, 1995.
  67. All-trans-retinoic-acid for acute promyelocytic leukaemia - the Hong Kong Scenario. 37th Annual Meeting of American Hematology Society, December 1995, No. 3000. Chim CS, Chu YC, Liang R, Kwong YL, Lee CK, Todd D, Chan TK.
  68. All-trans retinoic acid in the treatment of acute promyelocytic leukemia: The Hong Kong Scenario. Chim CS, YC Chu, YL Kwong, R Liang, CK Lee, D Todd, TK Chan. Blood p.753a, Vol 86, No.10, Suppl I, 1995.
  69. BCL-6 gene rearrangement in Hong Kong Chinese patients with lymphoma. R Liang, WP Chan, YL Kwong, Chim CS, CK Lee, A Chan, FCS Ho. Blood p.817a, Vol 86, No.10, Suppl I, 1995.
  70. Absence of Factor V gene mutation (1691 G to A) in Hong Kong Chinese patients with deep vein thrombosis (DVT). CK Lee, WP Chan, R Liang, YL Kwong, Chim CS, D Todd, TK Chan. Blood p.919a, Vol 86, No.10, Suppl I, 1995.
  71. Molecular detection of minimal residual disease (MRD) in adult and childhood all reveals differences in treatment response. L Foroni, LA Coyle, JC Yaxley, M Papaioannou, MF Cole Sinclair, Chim CS, PK Cannell, AB Mehta, HG Prentice, AV Hoffbrand. Blood p.330a, Vol 86, No.10, Suppl I, 1995.
  72. Molecular analysis of the leukemic B cell in adult and childhood acute lymphoblastic leukemia. L Foroni, LA Coyle, JC Yaxley, M Papaioannou, Chim CS, A Victor Hoffbrand. Blood p.728a, Vol 86, No.10, Suppl I, 1995.
  73. Comparative Study of four PCR-based methods in the study of minimal residual disease in B-lineage acute lymphoblastic leukemia. Chim CS, AV Hoffbrand, L Foroni. Hong Kong International Cancer Congress, 1994.
  74. To study the variable (v) gene, diversity (D) gene and joining region (J) gene usage in B-lineage acute lymphoblastic leukemia. Chim CS, AV Hoffbrand, L Foroni. Hong Kong International Cancer Congress, 1994.
  75. Minimal residual disease (MRD) analysis of Adult and children ALL. L Coyle, M Cole-Sinclair, Chim CS, P Cannell, F Wright, AB Metha, HG Prentice, AV Hoffbrand, L Foroni. Blood p.300a, Vol 84, No. 10, Suppl I, 1994.
  76. A Rapid Method for the detection of clonal B cell expansion and reaction (PCR). L Foroni, JC Yaxley, Chim CS, AV Hoffbrand and P Amlot. Blood, Vol 82, No. 10, Suppl I, 1993.

Local publications:

  1. JCS Chim. Cancer Treatment in the Era of Targeted Therapy: the March is on! Hong Kong Medical Diary, p.2-3, March issue, 2011.
  2. JCS Chim. To Optimise Myeloma Treatment in the Era of Targeted Therapy. P7-9. March issue, 2011
  3. JCS Chim. Demethylation Therapy in Haemic Cancer. Hong Kong Medical Diary, p.2-3, Aug issue, 2008
  4. JCS Chim. Epigenetic Therapy Comes of Age: Waking Up Silenced Tumour Suppressor Genes in Myelodysplastic Syndrome. Hong Kong Medical Diary, p.5-8, Aug issue, 2008
  5. Chim CS. Editorial: Molecular targets of therapy in haemic cancers. The Hong Kong Medical Diary. 12 (4), April 2007: 2-3.
  6. Chim CS. Review: Advances in the treatment of multiple myeloma: long awaited. The Hong Kong Medical Diary. 12 (4), April 2007: 6-8.
  7. Chim CS. HK Blood Cancer Group Newsletter: Jan, 2007

 

James CS Chim

Professor

 

  • : 2255 4769
    • DEPARTMENT Department of Medicine
      Division of Haematology & Oncology
      Queen Mary Hospital
      University of Hong Kong
    • COUNTRYHong Kong